Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 study of TRM-1, a TRAIL-R1 monoclonal antibody, in relapsed or refractory non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 3]
This Phase 3 trial evaluated cisplatin plus vinorelbine with or without tirapazamine in patients with stage IIIB or stage IV non-small cell …
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 trial in advanced non-small cell lung cancer evaluating hydroxychloroquine with or without erlotinib was terminated; results were po…
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC). [Phase 3]
A Phase 3, placebo-controlled trial of sorafenib in predominantly non-squamous non-small cell lung cancer after third or fourth line therapy…
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy followed by surgery for patients with stage IIIA non-small cell lung cancer has…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-24Clinical Trial Update: Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer [Phase 3]
Pfizer-sponsored Phase 3 trial evaluating figitumumab (CP-751,871) with erlotinib in refractory lung cancer was terminated and results were …
-
CLINICAL_TRIALS trial_result · 2013-07-22Clinical Trial Update: Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating carboplatin, paclitaxel, and bevacizumab with or without erlotinib hydrochloride for non-small cell lung cancer in …
-
CLINICAL_TRIALS trial_result · 2013-07-22Clinical Trial Update: 0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating apricoxib or placebo with docetaxel or pemetrexed in non-small cell lung cancer has completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating Ro 50-3821 to treat anemia in patients with stage IIIB or IV non-small cell lung cancer receiving antine…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer [Phase 1]
A Phase 1 study evaluated intravenous interleukin-4 PE38KDEL cytotoxin in patients with recurrent or metastatic breast cancer, renal cell ca…
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A phase 2 trial of temsirolimus (CCI-779) for stage IIIB (with pleural effusion) or stage IV non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-15Clinical Trial Update: Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy [Phase 2]
Phase 2 study evaluating the combination of carboplatin, gemcitabine, and bevacizumab in locally advanced or metastatic non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2013-07-12Clinical Trial Update: Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC [Phase 2]
This Phase 2 clinical trial evaluating carboplatin plus gemcitabine followed by concomitant chemoradiation for non-resectable stage III non-…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Temsirolimus and Radiation for Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating temsirolimus in combination with radiation therapy for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 study of DX-8951f in previously untreated stage IIIB or stage IV non-small cell lung cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial update evaluating the combination of chemotherapy, amifostine, and radiation therapy in patients with non-small cel…
-
CLINICAL_TRIALS trial_result · 2013-07-04Clinical Trial Update: Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC [Phase 2]
A Phase II trial of docetaxel and carboplatin with radiotherapy and surgical resection for stage III non-small cell lung cancer was terminat…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing surgery with and without chemotherapy in patients with Stage I non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial of veliparib with cisplatin and gemcitabine in advanced biliary tract, pancreatic, urothelial, and non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES) [Phase 3]
A Phase 3 clinical trial evaluated whether adding enoxaparin (LMWH) to first-line chemotherapy improves survival and symptom control in pati…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated a combination of docetaxel, cisplatin, pegfilgrastim, and erlotinib in patients with stage IIIB or stage IV non-sm…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 first-line trial of tamibarotene in combination for advanced non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating combination chemotherapy as induction therapy for stage III non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
This document reports results from a Phase 2 trial of TLK286 in patients with advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating induction Erlotinib in stage IIIA (N2) non-small cell lung cancer has completed.